2022 annual financial data
Edesa Biotech 2022 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -18,370,790 USD and net income was -17,548,924 USD.
Operating cash flow was -12,279,302 USD.
Get free Edesa Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -18,370,790 USD
- Net income
- -17,548,924 USD
- Operating cash flow
- -12,279,302 USD